 | Up a level |
Bagnoud, Maud; Remlinger, Jana; Joly, Sandrine; Massy, Marine; Salmen, Anke; Chan, Andrew; Karathanassis, Dimitris; Evangelopoulos, Maria-Eleptheria; Hoepner, Robert (2024). Predicting glucocorticoid resistance in multiple sclerosis relapse via a whole blood transcriptomic analysis. CNS neuroscience & therapeutics, 30(2), e14484. Wiley 10.1111/cns.14484
Remlinger, Jana; Bagnoud, Maud; Meli, Ivo; Massy, Marine; Linington, Christopher; Chan, Andrew; Bennett, Jeffrey L; Hoepner, Robert; Enzmann, Volker; Salmen, Anke (2023). Modelling MOG antibody-associated disorder and neuromyelitis optica spectrum disorder in animal models: Spinal cord manifestations. Multiple Sclerosis and Related Disorders, 78(104892), p. 104892. Elsevier 10.1016/j.msard.2023.104892
Bagnoud, Maud; Remlinger, Jana; Massy, Marine; Lodygin, Dmitri; Salmen, Anke; Chan, Andrew; Lühder, Fred; Hoepner, Robert (2023). In Vivo and In Vitro Evidence for an Interplay between the Glucocorticoid Receptor and the Vitamin D Receptor Signaling. Cells, 12(18) MDPI 10.3390/cells12182291
Remlinger, Jana; Bagnoud, Maud; Meli, Ivo; Massy, Marine; Hoepner, Robert; Linington, Christopher; Chan, Andrew; Bennett, Jeffrey L; Enzmann, Volker; Salmen, Anke (2023). Modeling MOG Antibody-Associated Disorder and Neuromyelitis Optica Spectrum Disorder in Animal Models: Visual System Manifestations. Neurology: Neuroimmunology and Neuroinflammation, 10(5) Wolters Kluwer Health 10.1212/NXI.0000000000200141
Remlinger, Jana; Madarasz, Adrian; Guse, Kirsten; Hoepner, Robert; Bagnoud, Maud; Meli, Ivo; Feil, Moritz; Abegg, Mathias; Linington, Christopher; Shock, Anthony; Boroojerdi, Babak; Kiessling, Peter; Smith, Bryan; Enzmann, Volker; Chan, Andrew; Salmen, Anke (2022). Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG-Associated Experimental Autoimmune Encephalomyelitis. Neurology: neuroimmunology & neuroinflammation, 9(2) Wolters Kluwer Health 10.1212/NXI.0000000000001134
Gili-Kovács, Judit; Hoepner, Robert; Salmen, Anke; Bagnoud, Maud; Gold, Ralf; Chan, Andrew; Briner, Myriam (2021). An algorithm using clinical data to predict the optimal individual glucocorticoid dosage to treat multiple sclerosis relapses. Therapeutic advances in neurological disorders, 14, p. 17562864211020074. Sage 10.1177/17562864211020074
Bagnoud, Maud; Briner, Myriam; Remlinger, Jana; Meli, Ivo; Schuetz, Sara; Pistor, Maximilian; Salmen, Anke; Chan, Andrew; Hoepner, Robert (2020). c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis. Cells, 9(10) MDPI 10.3390/cells9102154
Miclea, Andrei; Bagnoud, Maud; Chan, Andrew; Hoepner, Robert (2020). A Brief Review of the Effects of Vitamin D on Multiple Sclerosis. Frontiers in immunology, 11(781), p. 781. Frontiers Research Foundation 10.3389/fimmu.2020.00781
Hoepner, Robert; Bagnoud, Maud; Pistor, Maximilian; Salmen, Anke; Briner, Myriam; Synn, Helen; Schrewe, Lisa; Guse, Kirsten; Ahmadi, Farhad; Demir, Seray; Laverick, Louis; Gresle, Melissa; Worley, Paul; Reichardt, Holger Michael; Butzkueven, Helmut; Gold, Ralf; Metz, Imke; Lühder, Fred; Chan, Andrew (2019). Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis. Acta neuropathologica, 138(3), pp. 443-456. Springer-Verlag 10.1007/s00401-019-02018-8
Briner, Myriam; Bagnoud, Maud; Miclea, Andrei; Friedli, Christoph; Diem, Lara; Chan, Andrew; Hoepner, Robert; Salmen, Anke (2019). Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age. Therapeutic advances in neurological disorders, 12, p. 1756286419843450. Sage 10.1177/1756286419843450
Zoehner, Greta; Miclea, Andrei; Salmen, Anke; Kamber, Nicole; Diem, Lara; Friedli, Christoph; Bagnoud, Maud; Ahmadi, Farhad; Briner, Myriam; Sédille-Mostafaie, Nazanin; Kilidireas, Constantinos; Stefanis, Leonidas; Chan, Andrew; Hoepner, Robert; Evangelopoulos, Maria Eleftheria (2019). Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course. Therapeutic advances in neurological disorders, 12, p. 1756286419878340. Sage 10.1177/1756286419878340
